| scholarly article | Q13442814 |
| P50 | author | Peter Kraiczy | Q104975407 |
| Barbara C. Kahl | Q41674855 | ||
| P2093 | author name string | Thomas A Wichelhaus | |
| Volker Brade | |||
| Silke Besier | |||
| Johannes Zander | |||
| P2860 | cites work | Biofilms, antimicrobial resistance, and airway infection. | Q53956881 |
| Small-Colony Variants of Pseudomonas aeruginosa in Cystic Fibrosis | Q57542653 | ||
| Biological cost of hypermutation in Pseudomonas aeruginosa strains from patients with cystic fibrosis | Q61477562 | ||
| Clonal heterogeneity, distribution, and pathogenicity of methicillin-resistant Staphylococcus aureus | Q74293597 | ||
| Persistent infection with small colony variant strains of Staphylococcus aureus in patients with cystic fibrosis | Q74422423 | ||
| Genetic analysis of Bacillus subtilis mutator genes | Q78666892 | ||
| Molecular analysis of the thymidine-auxotrophic small colony variant phenotype of Staphylococcus aureus | Q80107472 | ||
| Transformation of MutL by ATP binding and hydrolysis: a switch in DNA mismatch repair | Q27617873 | ||
| Crystal structure and ATPase activity of MutL: implications for DNA repair and mutagenesis | Q27766073 | ||
| Identification of the cystic fibrosis gene: genetic analysis | Q29614402 | ||
| Differential effect of rpoB mutations on antibacterial activities of rifampicin and KRM-1648 against Staphylococcus aureus | Q31830904 | ||
| Hypermutable and fluoroquinolone-resistant clinical isolates of Staphylococcus aureus | Q33770211 | ||
| Distribution of genes encoding resistance to macrolides, lincosamides, and streptogramins among staphylococci | Q33976201 | ||
| Clinical isolates of Staphylococcus aureus with ribosomal mutations conferring resistance to macrolides | Q34112287 | ||
| High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. | Q34508854 | ||
| Stage-specific adaptation of hypermutable Pseudomonas aeruginosa isolates during chronic pulmonary infection in patients with cystic fibrosis | Q34588476 | ||
| The Escherichia coli MutL protein stimulates binding of Vsr and MutS to heteroduplex DNA. | Q34657088 | ||
| The cystic fibrosis transmembrane conductance regulator gene | Q34719664 | ||
| Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis | Q35557791 | ||
| Prevalence and clinical significance of Staphylococcus aureus small-colony variants in cystic fibrosis lung disease | Q35690337 | ||
| Population dynamics of persistent Staphylococcus aureus isolated from the airways of cystic fibrosis patients during a 6-year prospective study | Q35922391 | ||
| Mutations in the DNA mismatch repair proteins MutS and MutL of oxazolidinone-resistant or -susceptible Enterococcus faecium | Q36048384 | ||
| Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections | Q36422855 | ||
| DNA mismatch repair system. Classical and fresh roles | Q36453321 | ||
| Hypermutable bacteria isolated from humans--a critical analysis | Q36583214 | ||
| Prevalence of thymidine-dependent Staphylococcus aureus in patients with cystic fibrosis | Q37215494 | ||
| Dynamics of long-term colonization of respiratory tract by Haemophilus influenzae in cystic fibrosis patients shows a marked increase in hypermutable strains | Q37421041 | ||
| Bacillus subtilis mutS mutL operon: identification, nucleotide sequence and mutagenesis | Q38354717 | ||
| Dominant negative mutator mutations in the mutL gene of Escherichia coli | Q39716760 | ||
| Thymidine-dependent small-colony variants of Staphylococcus aureus exhibit gross morphological and ultrastructural changes consistent with impaired cell separation | Q39732905 | ||
| Influence of dTMP on the phenotypic appearance and intracellular persistence of Staphylococcus aureus | Q40030687 | ||
| Emergence of phenotypic variants upon mismatch repair disruption in Pseudomonas aeruginosa | Q40557981 | ||
| Prognosis in cystic fibrosis. | Q41638180 | ||
| Occurrence of hypermutable Pseudomonas aeruginosa in cystic fibrosis patients is associated with the oxidative stress caused by chronic lung inflammation | Q41825397 | ||
| In vivo mutations of thymidylate synthase (encoded by thyA) are responsible for thymidine dependency in clinical small-colony variants of Staphylococcus aureus | Q41911383 | ||
| Hypermutation is a key factor in development of multiple-antimicrobial resistance in Pseudomonas aeruginosa strains causing chronic lung infections | Q41974061 | ||
| Inactivation of the mismatch repair system in Pseudomonas aeruginosa attenuates virulence but favors persistence of oropharyngeal colonization in cystic fibrosis mice. | Q42560500 | ||
| Role of mutS and mutL genes in hypermutability and recombination in Staphylococcus aureus | Q42754912 | ||
| High Rate of Macrolide Resistance inStaphylococcus aureusStrains from Patients with Cystic Fibrosis Reveals High Proportions of Hypermutable Strains | Q44195004 | ||
| Multiresistant pulmonary infection in cystic fibrosis--prevention is better than cure | Q44600593 | ||
| Analysis of the quaternary structure of the MutL C-terminal domain | Q46604277 | ||
| Spontaneous mutators in bacteria: insights into pathways of mutagenesis and repair | Q46617407 | ||
| High mutation frequencies among Escherichia coli and Salmonella pathogens | Q48057867 | ||
| Fatal outcome of lung transplantation in cystic fibrosis patients due to small-colony variants of the Burkholderia cepacia complex. | Q51678317 | ||
| Mutations are involved in emergence of aminoglycoside-induced small colony variants of Staphylococcus aureus. | Q51715244 | ||
| Insertional inactivation of mutS in Staphylococcus aureus reveals potential for elevated mutation frequencies, although the prevalence of mutators in clinical isolates is low. | Q52861291 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Staphylococcus aureus | Q188121 |
| antibiotic resistance | Q380775 | ||
| P304 | page(s) | 2183-2189 | |
| P577 | publication date | 2008-03-31 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | The thymidine-dependent small-colony-variant phenotype is associated with hypermutability and antibiotic resistance in clinical Staphylococcus aureus isolates | |
| P478 | volume | 52 |
| Q35862882 | Activation of the SOS response increases the frequency of small colony variants |
| Q34017905 | Adaptive evolution of Staphylococcus aureus during chronic endobronchial infection of a cystic fibrosis patient |
| Q41190866 | Altered Competitive Fitness, Antimicrobial Susceptibility, and Cellular Morphology in a Triclosan-Induced Small-Colony Variant of Staphylococcus aureus |
| Q30597709 | Antibiotic activity against small-colony variants of Staphylococcus aureus: review of in vitro, animal and clinical data |
| Q37887170 | Antibiotic treatment of CF lung disease: from bench to bedside |
| Q38185117 | Antibiotrophs: The complexity of antibiotic-subsisting and antibiotic-resistant microorganisms. |
| Q50908688 | Antimicrobial susceptibility and molecular typing of MRSA in cystic fibrosis. |
| Q37794342 | Bacterial hypermutation in cystic fibrosis, not only for antibiotic resistance |
| Q34491552 | Clinical significance of microbial infection and adaptation in cystic fibrosis |
| Q50056870 | Distribution of mutation frequencies among Salmonella enterica isolates from animal and human sources and genetic characterization of a Salmonella Heidelberg hypermutator |
| Q92648818 | Evaluation of agar culture plates to efficiently identify small colony variants of methicillin-resistant Staphylococcus aureus |
| Q36559344 | Evolution in fast forward: a potential role for mutators in accelerating Staphylococcus aureus pathoadaptation |
| Q44350722 | Hypermutable Staphylococcus aureus strains present at high frequency in subclinical bovine mastitis isolates are associated with the development of antibiotic resistance |
| Q37922538 | Hypermutation and stress adaptation in bacteria |
| Q36949434 | Identification of the genetic basis for clinical menadione-auxotrophic small-colony variant isolates of Staphylococcus aureus |
| Q34933382 | Impact of ciprofloxacin exposure on Staphylococcus aureus genomic alterations linked with emergence of rifampin resistance |
| Q57801442 | In vivo competition and horizontal gene transfer among distinct Staphylococcus aureus lineages as major drivers for adaptational changes during long-term persistence in humans |
| Q38763542 | Infection in cystic fibrosis: impact of the environment and climate. |
| Q42206103 | Infection prevention and control guideline for cystic fibrosis: 2013 update |
| Q34737534 | Intra- and extracellular activities of dicloxacillin and linezolid against a clinical Staphylococcus aureus strain with a small-colony-variant phenotype in an in vitro model of THP-1 macrophages and an in vivo mouse peritonitis model |
| Q37144809 | Intracellular activity of antibiotics in a model of human THP-1 macrophages infected by a Staphylococcus aureus small-colony variant strain isolated from a cystic fibrosis patient: pharmacodynamic evaluation and comparison with isogenic normal-pheno |
| Q37144883 | Intracellular activity of antibiotics in a model of human THP-1 macrophages infected by a Staphylococcus aureus small-colony variant strain isolated from a cystic fibrosis patient: study of antibiotic combinations |
| Q42850242 | Lack of association of small-colony-variant Staphylococcus aureus strains with long-term use of azithromycin in patients with cystic fibrosis |
| Q46777863 | Mutability in Pseudomonas viridiflava as a programmed balance between antibiotic resistance and pathogenicity. |
| Q34596507 | PBP2a mutations causing high-level Ceftaroline resistance in clinical methicillin-resistant Staphylococcus aureus isolates. |
| Q34297656 | Pharmacokinetics and pharmacodynamics of aerosolized antibacterial agents in chronically infected cystic fibrosis patients |
| Q42045562 | Phenotype switching is a natural consequence of Staphylococcus aureus replication |
| Q92494196 | Phenotypic Stability of Staphylococcus Aureus Small Colony Variants (SCV) Isolates from Cystic Fibrosis (CF) Patients |
| Q26786112 | Phenotypic and Genotypic Characteristics of Small Colony Variants and Their Role in Chronic Infection |
| Q37849394 | Population biological principles of drug-resistance evolution in infectious diseases |
| Q36018436 | Rapid Acquisition of Linezolid Resistance in Methicillin-Resistant Staphylococcus aureus: Role of Hypermutation and Homologous Recombination |
| Q42421215 | Role of mutations in dihydrofolate reductase DfrA (Rv2763c) and thymidylate synthase ThyA (Rv2764c) in Mycobacterium tuberculosis drug resistance |
| Q35069183 | The genetic basis of Escherichia coli pathoadaptation to macrophages. |
| Q35807037 | Thymidine auxotrophic Staphylococcus aureus small-colony variant endocarditis and left ventricular assist device infection |
| Q36290528 | Thymidine-Dependent Staphylococcus aureus Small-Colony Variants Are Induced by Trimethoprim-Sulfamethoxazole (SXT) and Have Increased Fitness during SXT Challenge |
| Q36957900 | Thymidine-dependent Staphylococcus aureus small-colony variants: human pathogens that are relevant not only in cases of cystic fibrosis lung disease |
Search more.